X 

AFFLUENCE
Go
Company News
Home | Market Info | Company Profile | Company News
Equity
 
 
Price Analysis
Gainers & Losers
Out & Under Performers
Only Buyers & Sellers
Highs & Lows
Advances & Declines
Weightage
5 Day's Up & Down
Historical Returns
Heat Map
Volume Analysis
Most Active
Block Deals
Bulk Deals
Highest / Lowest Delivery
Index Analysis
Live Indices
Rising VDP
Rise Volume, Delivery & Fall in Price
News Analysis
Hot Stocks
Other Market
Corporate News
Market Pulse
Economy
Company Result
FII Position
Opening Bell
Midday Review
Closing Bell
Current Affairs & Politics
Global Markets
Mutual Fund News
Market Commentary
Corporate Action
BSE Announcements
Book Closure
Board Meetings
Bonus Issues
Right Issues
Split of Face Value
Dividend Details
Delisted Companies
Change of Name
Other Market
FII Investments
DII Investments
World Indices
ADR Prices
Company Profile
Smart Quotes
Company Background
Board Of Directors
Balance Sheet
Profit & Loss
Quarterly Results
Financial Ratios
Share Price
MF Holdings
Price Charts
Company News
Company Chart
Cash Flow
Share Holdings
Deliverable Volume
Historical Volume
Directors Report
Peer Comparison
Board Meetings
Corporate Announcements
Book Closure
Bonus Issues
AGM
Company List
Akums Drugs & Pharmaceuticals Ltd.
BSE CODE: 544222   |   NSE CODE: AKUMS   |   ISIN CODE : INE09XN01023   |   15-May-2025 Hrs IST
BSE NSE
Rs. 560.60
41.85 ( 8.07% )
 
Prev Close ( Rs.)
518.75
Open ( Rs.)
518.90
 
High ( Rs.)
563.00
Low ( Rs.)
517.10
 
Volume
29901
Week Avg.Volume
12209
 
52 WK High-Low Range(Rs.)
BSE NSE
Rs. 558.00
38.2 ( 7.35% )
 
Prev Close ( Rs.)
519.80
Open ( Rs.)
524.75
 
High ( Rs.)
562.50
Low ( Rs.)
516.10
 
Volume
527523
Week Avg.Volume
254867
 
52 WK High-Low Range(Rs.)
405
1175.9
26-Mar-2025 Akums Drugs and Pharmaceuticals informs about resignation of senior management personnel
15-Feb-2025 Akums Drugs secures patent for 'Benzalkonium Chloride-Free Brinzolamide Ophthalmic Formulation'
15-Feb-2025 Akums Drugs and Pharmaceuticals informs about newspaper publication
07-Feb-2025 Akums Drugs and Pharmaceuticals reports 66% drop in Q3 consolidated net profit
03-Feb-2025 Akums Drugs and Pharmaceuticals informs about analyst meet
22-Jan-2025 Akums Drugs and Pharmaceuticals informs about disclosure
24-Dec-2024 Akums Drugs enters into agreement for manufacture, supply of selected pharmaceutical formulations
26-Nov-2024 Akums Drugs’ arm collaborates with Jagdale Industries
26-Nov-2024 Akums Drugs and Pharmaceuticals informs about updates
21-Nov-2024 Akums Drugs touches roof on the BSE
Page 1 of 3
PREV || NEXT
"Prevent unauthorized transactions in your account --> Update your mobile numbers/email IDs with your stock brokers. Receive information of your transactions directly from Exchange on your mobile/email at the end of the day .......... Issued in the interest of Investors " Update your Mobile Number with your Depository Participant. Receive alerts on your Registered Mobile for all debit and other important transactions in your demat account directly from NSDL/CDSL on the same day..... issued in the interest of investors. " "KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary." "No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorize your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account" "Client may please note that, we do trade in Proprietary/Own Account" Clients are advised to provide “Self Certification” under Rule 114H (8) of the Income tax Rules, 1962 under alternative procedure of FATCA on or before April 30, 2017. In case of self-certifications are not provided, your account would be blocked & thereafter you may not be permitted to do transaction without submitting the same. FATCA Form has been sent on your registered email id. You may also download the form from our website under “download>Forms>FATCA/CRS Declaration” & submit the same at our office or by email. Have you linked your Aadhaar to your Trading & demat yet? To link your Aadhaar, “Provide your duly signed copy of Aadhaar Card.” please visit: 4Th Floor, A-6, Safal Profitaire, Corporate Road, Opp. Auda Garden, Prahlad Nagar, Satellite, Ahmedabad - 380051. "In case of any grievances, you can approach us at our IG Email ID : trading.grievances@affluence.ooo , however If you are not satisfied with the grievance redressed by us, you can also approach https://scores.gov.in/scores/Welcome.html".   Investors beware of unsolicited Messages: https://www.nseindia.com/regulations/unsolicited-messages-report https://www.bseindia.com/attention_investors.aspx" As a business we don't give stock tips, and have not authorized anyone to trade on behalf of others. If you find anyone claiming to be part of AFFLUENCE SHARES AND STOCKS PRIVATE LIMITED and offering such services, please send us an email to compliance@affluence.ooo "The Stock Exchange, Mumbai is not in any manner answerable, responsible or liable to any person or persons for any acts of omission or commission, errors, mistakes and/or violation, actual or perceived, by us or our partners, agents, associates etc., of any of the Rules, Regulations, Bye-laws of the Stock Exchange, Mumbai, SEBI Act or any other laws in force from time to time. The Stock Exchange, Mumbai is not answerable, responsible or liable for any information on this Website or for any services rendered by our employees, our servants, and us."
Attention Investors 1.Stock Brokers can accept securities as margin from clients only by way of pledge in the depository system w.e.f. September 1, 2020. 2. Update your mobile number & email Id with your stock broker/depository participant and receive OTP directly from depository on your email id and/or mobile number to create pledge. 3.Pay 20% upfront margin of the transaction value to trade in cash market segment. 4.Investors may please refer to the Exchange's Frequently Asked Questions (FAQs) issued vide circular reference NSE/INSP/45191 dated July 31, 2020 and NSE/INSP/45534 dated August 31, 2020 and other guidelines issued from time to time in this regard. Continuation Sheet 5.Check your Securities /MF/ Bonds in the consolidated account statement issued by NSDL/CDSL every month Issued in the interest of Investors
Advisory to Investors

If you want to register your complaints through SEBI Score Portal please Click here

About UsCareers Downloads
Feedback Corporate Announcements Client Collateral Details
Investor Complaints Data - Stock Brokers Investor Complaints Data - DP Investor Charter-Stock Brokers Investor Charter-DP
connect with us facebook twitter linkedin googleplus youtube
Corporate / Register Office:  A-6 | 4TH FLOOR | SAFAL PROFITAIRE | CORPORATE ROAD |
PRAHLADNAGAR | AHMEDABAD – 380051 |GUJARAT | INDIA.
Tel: +91 79 6777 6555 | +91 79 4077 6555 | Fax: +91 79 6777 6556
SEBI REG NO: Affluence Shares & Stocks Private Limited – INZ000173635 | IN DP-381-2018
MEMBER ID:- NSE:14691 | BSE:3032 | MCX:56115 | NCDEX:01257
Clearing Member Detail: Globe Capital Market Limited |
Address: 609, Ansal Bhawan, 16, K. G. Marg, Connaught Place, New Delhi-110 001
SEBI Reg.No.: INZ000177137 | CM No.: NSE(FO/CD) : M50302 |
MCX : 8090 | NCDEX : M51085 | BSEFO : 3179
In case of grievances for Securities Broking write to compliance@affluence.ooo
Useful Links: BSE| NSE | MCX | NCDEX | CDSL | SEBI | RBI | CDSL E-Voting | SMART ODR Portal

Copyright @ 2015 Affluence
Terms of Use | Disclaimer | Privacy Policy | Feedback
Investor Protection | Broker Norms | Site map
Designed, Developed & Content Powered by  ●●● Accord Fintech Pvt. Ltd.
Feedback
Name *
Email *
Your Message:*
*Fields are mandatory
 X 
Careers
Name *
Address 1 *
Address 2 *
City *
Mobile * +91
Email *
Upload Resume *
*Fields are Mandatory  
 X